Sign in

Hypertrophic cardiomyopathy trials, also abroad

89 open Hypertrophic cardiomyopathy trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States21
China19
United Kingdom14
Germany11
France8
Italy8
Austria6
Poland5
Canada4
Netherlands4
Belgium3
Portugal3
Russia3
Argentina2
Brazil2
Czechia2
Denmark2
Japan2
South Korea2
Sweden2
Australia1
Egypt1
Greece1
Hungary1
Israel1
Iceland1
Puerto Rico1
Singapore1
Türkiye1
Taiwan1

The same trial often runs in several countries

Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM has 13 sites in Spain and runs in 19 countries. If a site near you is full, another one may still take people.

See Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM in all 19 countries